Advertisement
Collaboration › Details
BASF–MIT: CRISPR technology, 201810– license ww non-excl to CRISPR-Cpf1 technology from Broad Institute for agriculture + industrial microbiology
Period | 2018-10-24 | |
Region | ALL | |
Predecessor | BASF–MIT: CRISPR technology, 201703– license ww for agricultural + industrial microbiology applications from Broad Institute | |
Partner, 1st | BASF S.E. | |
Group | BASF (Group) | |
Partner, 2nd | Broad Institute (MIT / Harvard) | |
Group | MIT (Massachusetts Institute of Technology) | |
Product | CRISPR gene editing technology | |
Product 2 | AGRI LIFE SCIENCES | |
Person | Eckes, Peter (BASF 201201 President of BASF Plant Science) | |
Person 2 | Rozen, Issi (Alphabet 202108 Venture Partner at GV before MIT 201703 CBO at Broad Institute) | |
BASF SE. (10/24/18). "Press Release: BASF Licenses CRISPR-Cpf1 Genome Editing Technology from the Broad Institute of MIT and Harvard". Research Triangle Park, NC.
BASF has attained a global, non-exclusive licensing agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cpf1 genome editing technology to improve products in agricultural and industrial microbiology applications.
CRISPR-Cpf1 has demonstrated distinct advantages for certain applications over CRISPR-Cas9, which BASF has previously licensed from the Broad Institute. By adding CRISPR-Cpf1 to its portfolio, BASF has the flexibility to choose the right tool for specific applications. Access to both technologies will also help to accelerate the development of new agricultural and industrial microbiology products.
“Genome editing tools represent the next step in molecular biology innovation,” said Peter Eckes, President of BASF Bioscience Research. “The addition of CRISPR-Cpf1 greatly expands our technological capabilities in modern agriculture and industrial solutions and we are eager to see how these technologies will improve multiple products in these areas.”
“This technology represents a transformative application of genome editing for the research community,” said Issi Rozen, Chief Business Officer of the Broad Institute. “CRISPR-Cpf1 can directly benefit advanced research across many industries including human health and agriculture. We are proud to partner with stakeholders throughout the biomedical and agriculture community to help deliver responsible solutions for our planet.”
About BASF
BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has more than 18,200 employees in North America, and had sales of $17.9 billion in 2017. For more information about BASF’s North American operations, visit www.basf.com.
At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. The more than 115,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions and Oil & Gas. BASF generated sales of €64.5 billion in 2017. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (BAS). Further information at www.basf.com.
Betsy Arnone
+1 973 245-7865
Send Mail
Birgit Lau
Research & Innovation, Nanotechnology, Agricultural Solutions
+49 621 60-20732
Send Mail
Record changed: 2018-11-03 |
Advertisement
More documents for BASF (Group)
- [1] Lonza Group Ltd.. (3/23/22). "Press Release: Christian Seufert Appointed as President of Capsules and Health Ingredients Division". Basel....
- [2] BASF SE. (5/3/21). "Press Release: BASF Strengthens Its Global Production Footprint for Enzymes. BASF Will Invest at Novartis’ Kundl/Schaftenau Campus, in Austria"....
- [3] Merck KGaA. (8/6/20). "Press Release: Leadership Change within Group Communications at Merck". Darmstadt....
- [4] Chemovator GmbH. (5/28/20). "Press Release: BASF Startup Incubator Celebrates Second Anniversary and faCellitate Product Launch". Mannheim....
- [5] BASF AG. (2/20/19). "Press Release: BASF’s Investment into Alchemist Accelerator Promotes Digital Innovations in the Chemical Industry". San Francisco, CA & Ludwigshafen....
- [6] BASF SE. (10/24/18). "Press Release: BASF Licenses CRISPR-Cpf1 Genome Editing Technology from the Broad Institute of MIT and Harvard". Research Triangle Park, NC....
- [7] BRAIN AG. (10/10/18). "Press Release: Ludger Roedder to join BRAIN AG Management Board as Chief Business Officer (CBO)". Zwingenberg....
- [8] BASF SE. (7/17/17). "Press Release: BASF and Kaiima Announce Collaboration to Identify Novel Herbicide Resistance Traits Using the EP Technology Platform". Limburgerhof & Moshav Sharona....
- [9] BASF SE. (7/13/17). "Press Release: BASF Introduces First New Class of Public Health Insecticide for Malaria Prevention in more than 30 Years". Limburgerhof....
- [10] BASF Corporation. (3/22/17). "Press Release: BASF Licenses CRISPR-Cas9 Genome-editing Technology from the Broad Institute". Research Triangle Park, NC....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top